William D. Clark - 31 May 2022 Form 4 Insider Report for GENOCEA BIOSCIENCES, INC.

Role
President and CEO, Director
Signature
/s/ DIANTHA DUVALL, ATTORNEY-IN-FACT FOR WILLIAM CLARK
Issuer symbol
N/A
Transactions as of
31 May 2022
Net transactions value
-$7,234
Form type
4
Filing time
02 Jun 2022, 16:31:04 UTC
Previous filing
05 Apr 2022
Next filing
03 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GNCA Common Stock Sale $7,234 -117,244 -28% $0.0617* 308,400 31 May 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1. Represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $0.061 to $0.0628, inclusive.